These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 11356940)

  • 1. A high-capacity quantitative mouse model of drug-mediated immunosuppression based on rejection of an allogeneic subcutaneous tumor.
    Hammond-McKibben D; Lake P; Zhang J; Tart-Risher N; Hugo R; Weetall M
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1144-51. PubMed ID: 11356940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
    Silva FR; Silva LB; Cury PM; Burdmann EA; Bueno V
    Int Immunopharmacol; 2006 Dec; 6(13-14):1911-8. PubMed ID: 17161344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
    Roos M; Liu S; Strobl M; Schmaderer C; Baumann M; Heemann U; Lutz J
    Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
    Sakagawa T; Kiyochi H; Honda K; Kobayashi N
    Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppression with FTY720 and cyclosporine A inhibits rejection of adult porcine islet xenografts in rats.
    Maeda A; Goto M; Zhang J; Bennet W; Groth CG; Korsgren O; Wennberg L
    Transplantation; 2003 Apr; 75(8):1409-14. PubMed ID: 12717240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FTY720 treatment prolongs skin graft survival in a completely incompatible strain combination.
    Lima RS; Nogueira-Martins MF; Silva HT; Pestana JO; Bueno V
    Transplant Proc; 2004 May; 36(4):1015-7. PubMed ID: 15194353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
    Huang WH; Yan Y; De Boer B; Bishop GA; House AK
    Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
    Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
    Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses.
    Majewski M; Korecka M; Joergensen J; Fields L; Kossev P; Schuler W; Shaw L; Wasik MA
    Transplantation; 2003 May; 75(10):1710-7. PubMed ID: 12777861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The thymus is required for the ability of FTY720 to prolong skin allograft survival across different histocompatibility MHC barriers.
    del Rio ML; Pabst O; Ramirez P; Penuelas-Rivas G; Förster R; Rodriguez-Barbosa JI
    Transpl Int; 2007 Oct; 20(10):895-903. PubMed ID: 17854447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
    Koshiba T; Van Damme B; Rutgeerts O; Waer M; Pirenne J
    Transplantation; 2003 Apr; 75(7):945-52. PubMed ID: 12698078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of lymphocyte apoptosis and prolongation of allograft survival by FTY720.
    Suzuki S; Li XK; Shinomiya T; Enosawa S; Kakefuda T; Mitsusada M; Amemiya H; Takahara S; Amari M; Naoe S; Hoshino Y; Chiba K
    Transplant Proc; 1996 Aug; 28(4):2049-50. PubMed ID: 8769151
    [No Abstract]   [Full Text] [Related]  

  • 13. The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1.
    Schmid G; Guba M; Ischenko I; Papyan A; Joka M; Schrepfer S; Bruns CJ; Jauch KW; Heeschen C; Graeb C
    J Cell Biochem; 2007 May; 101(1):259-70. PubMed ID: 17203465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of cyclosporine A and SDZ RAD on neointima formation of carotid allografts in apolipoprotein E-deficient mice.
    Matsumoto Y; Hof A; Baumlin Y; Hof RP
    Transplantation; 2003 Oct; 76(8):1166-70. PubMed ID: 14578747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTY720 inhibits TH1-mediated allogeneic humoral immune response.
    Peñuelas-Rivas G; Domínguez-Perles R; Brinkmann V; Del Rio ML; Muñoz-Luna A; Ramírez-Romero P; Parrilla-Paricio P; Rodríguez-Barbosa JI
    Transplant Proc; 2005 Nov; 37(9):4124-6. PubMed ID: 16386642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
    Li J; Xia J; Zhang K; Xu L
    J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new immunosuppressant, FTY720, in canine kidney transplantation: effect of single-drug, induction and combination treatments.
    Suzuki T; Jin MB; Shimamura T; Yamashita K; Taniguchi M; Nomura M; Yokota R; Fukai M; Magata S; Horiuchi H; Fujita M; Nagashima K; Furukawa H; Todo S
    Transpl Int; 2004 Nov; 17(10):574-84. PubMed ID: 15592714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Subrenal capsule assay using nude mice].
    Kikuchi H; Asamura M; Gamoh M; Ohuchi H; Wakui A
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):532-41. PubMed ID: 2321981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation for synergistic suppression of T cell responses to minor histocompatibility antigens by chloroquine in combination with tacrolimus and a rapamycin derivative, SDZ-RAD.
    Hsiao CC; Su WN; Forooghian F; Bader S; Rempel J; HayGlass KT; Gilman A; Schultz KR
    Bone Marrow Transplant; 2002 Dec; 30(12):905-13. PubMed ID: 12476284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of intestinal allograft rejection by FTY720 and costimulation blockade.
    Yan S; Rodriguez-Barbosa JI; Pabst O; Beckmann JH; Brinkmann V; Förster R; Hoffmann MW
    Transplant Proc; 2005; 37(1):114-5. PubMed ID: 15808565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.